WO2008038807A1 - External composition for skin - Google Patents

External composition for skin Download PDF

Info

Publication number
WO2008038807A1
WO2008038807A1 PCT/JP2007/069111 JP2007069111W WO2008038807A1 WO 2008038807 A1 WO2008038807 A1 WO 2008038807A1 JP 2007069111 W JP2007069111 W JP 2007069111W WO 2008038807 A1 WO2008038807 A1 WO 2008038807A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
bht
external
composition
present
Prior art date
Application number
PCT/JP2007/069111
Other languages
French (fr)
Japanese (ja)
Inventor
Shigeki Sawamura
Original Assignee
Kobayashi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co., Ltd. filed Critical Kobayashi Pharmaceutical Co., Ltd.
Publication of WO2008038807A1 publication Critical patent/WO2008038807A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/75Anti-irritant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin

Definitions

  • the present invention relates to a composition for external use on skin having an itching suppression effect, a massage effect and the like.
  • the power of performing massage or the like to obtain a beauty or relaxation effect For example, the power of performing massage or the like to obtain a beauty or relaxation effect.
  • water-insoluble particles are blended as a scrub agent in order to exert a massage effect by physical stimulation.
  • scrubbing agents hard scrubbing agents such as polyethylene beads, talmi shell grains, and crystalline cellulose are widely used. Although hard scrubs are excellent in removing dirt on the skin and in massaging the skin, there are cases in which unpleasant skin irritation or foreign body sensation is felt during use.
  • itch is defined as “a sensation that causes the skin to break! /, And! /”, And is generally an unpleasant sensation.
  • Symptoms associated with “itch” include various forms such as atopic dermatitis, urticaria, insect bites, dry skin, and hypersensitive skin.
  • antihistamines, local anesthetics, moisturizing Agents are used. However, since they penetrate into the inner surface of the skin and involve a scientific approach, it takes time to take effect.
  • Patent Document 1 discloses an external preparation for skin containing natural oils and fats and antioxidants.
  • butylhydroxytoluene is generally added in an amount of about 0.0 ;! to 1% as a preservative, stabilizer, antioxidant and the like.
  • these external preparations have also been unable to effectively suppress the skin rather than those intended to irritate the skin.
  • Patent Document 1 JP 2000-159678 Disclosure of the invention
  • the main object of the present invention is to provide an external preparation for skin that gives skin irritation by application and exhibits a comfortable massage effect.
  • Another object of the present invention is to provide an external composition for skin, which can replace itching caused by insects and hypersensitivity skin with irritation, and can effectively suppress itching. Is.
  • BHT ptylhydroxytonolene
  • the present invention provides the following external composition for skin.
  • Item 1 A composition for external use on skin, characterized by containing solid-state butylhydroxytoluene (hereinafter referred to as BHT).
  • BHT solid-state butylhydroxytoluene
  • Item 2 The external composition for skin according to Item 1, wherein the particle size of BHT is 1000 m or less.
  • Item 4 The composition for external application to skin according to any one of Items 1 to 3, wherein the BHT content is 10 to 40% by weight.
  • Item 5 The external composition for skin according to any one of Items 1 to 4, further comprising a water-soluble polymer.
  • the invention's effect [0009]
  • the external composition for skin according to the present invention is applied directly to the skin, and the BHT in a solid state physically stimulates the skin, so that an appropriate massage stimulus can be given to the skin.
  • the composition for external use of the skin of the present invention when applied to an affected area having itching, it can be replaced with a feeling of irritation in a short time by physical stimulation of BHT in a solid state, and the itching is effectively suppressed. can do.
  • composition for external use of the skin of the present invention is characterized mainly by containing BHT in a solid state.
  • BHT BHT
  • the antipruritic agent of this invention contains BHT as an essential component.
  • Ptylhydroxytoluene is a compound having a white crystal shape, and both 1S, also called dibutylhydroxytoluene, refer to the same compound ([(CH 3) C] C H (CH 2) OH).
  • BHT traditionally makeup
  • antioxidants and stabilizers for foods, pharmaceuticals, foods and the like.
  • BHT commercially available ones can be used.
  • butyl hydroxytoluene (Sanei Chemical Co., Ltd.), dibutylhydroxytoluene (Eastman Chemica Norre Japan Co., Ltd., Ueno Pharmaceutical Co., Ltd.) API Corporation, Sumitomo Chemical Co., Ltd., Nagase Sangyo Co., Ltd., JGC Universal Co., Ltd., Mitsubishi Wel Pharma Co., Ltd.).
  • the particle size of BHT used in the present invention is about lOOOO ⁇ m or less, preferably about 1000 to 50 to 111, more preferably about 1000 to; about 100 to m, more preferably about 1000 to; About 180 in.
  • BHT having each particle diameter can be obtained by pulverizing BHT with a mortar or the like and then applying it to a sieve having each diameter.
  • Preferred combinations include, for example, (a) 501-; about 1000 m A combination of BHT with a particle size of and ⁇ having a particle size of about 350 to 500 ⁇ m; (b) BHT with a particle size of less than 350 [Im and a particle size of about 350 to 500 ⁇ m A combination of BHT having
  • the blending ratio of BHT having each particle size is appropriately set as long as the substitution effect on the irritating feeling of itchiness can be exhibited.
  • BHT having a particle size of about 501 to 1000 m is set to 0.
  • the amount of BHT in the external composition for skin of the present invention is about 10 to 40% by weight, preferably about 15 to 35% by weight, more preferably about 20 to 30% by weight. With such a blending amount, the massage effect and the antipruritic effect due to skin irritation can be exhibited more significantly while maintaining the stability as a preparation.
  • the composition for external use of the present invention preferably contains alcohol in addition to the BHT.
  • alcohol By blending alcohol, solid-state BHT can be dispersed favorably, and the skin can be uniformly and moderately stimulated.
  • the alcohol used in the present invention is not particularly limited as long as it is commonly used in the fields of cosmetics and pharmaceuticals. For example, methanol, ethanol, propanol, isopropanol, butanol, isobutanol and the like are used.
  • Lower alcohol having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms; propylene glycol, dipropylene glycol, glycerin, 1,3-butylene glycol, butylene glycol, concentrated glycerin, polyethylene glycol, maltitol, mannitol, sorbitol, etc.
  • Examples include polyhydric alcohols. these May be used alone or in combination of two or more.
  • the lower alcohol may be anhydrous or hydrated. In the present invention, it is preferable to use (hydrous) ethanol, absolute ethanol, or isopropanol!
  • the blending amount of alcohol in the composition for external use of the present invention is about 0 to 45% by weight, preferably about 4 to 40% by weight, more preferably about 4 to 35% by weight.
  • the blending ratio of BHT and alcohol in the external composition for skin of the present invention is such that when BHT is 1 part by weight, alcohol is about 3 parts by weight or less, preferably about 2 parts by weight or less, and more preferably about 1 part by weight or less. With such a blending ratio, the solid state of BHT can be maintained and an appropriate stimulus can be given to the skin.
  • the external composition for skin of the present invention may contain water, a water-soluble polymer, or the like, if necessary.
  • Conventionally known water-soluble polymers can be used, for example, carboxyvininole polymer, polyvinyl alcohol, polyvinyl methyl ether, polyvinylinoxychetyl cellulose, pullulan, agar, gelatin, alginic acid and its salts, carrageen Examples include naan and gums. These may be used alone or in combination of two or more.
  • the amount of water in the external composition for skin of the present invention is about 25 to 89.5% by weight, preferably about 27 to 80.2% by weight, more preferably about 28 to 75% by weight;
  • the amount of the conductive polymer to be combined is about 0.5 to 5% by weight, preferably about 0.8 to 4% by weight, and more preferably about 1 to 3% by weight.
  • Typical formulation examples of the present invention 10 to 40 weight BHT 0/0, the Anorekonore 0-45 wt%, a water-soluble polymer 0.5 to 5% by weight, water 25-89.
  • a composition for external use containing 5% by weight is exemplified.
  • the composition for external use of the skin of the present invention includes various components generally used in cosmetics, quasi-drugs, pharmaceuticals, aqueous components, oil-based components, moisturizing components, moisturizing components, and so on.
  • Forms, thickeners, preservatives, antioxidants, pH adjusters, carriers, fragrances, colorants, drugs and the like can be prepared in various dosage forms alone or in combination of two or more.
  • the composition for external use of the skin of the present invention includes a known local anesthetic and antibacterial agent within the range not impairing the effects of the present invention.
  • local anesthetics such as lidocaine, dibu force in, dibu force in hydrochloride, diphenhydramine, ethyl aminobenzoate, desitthecin; chlorpheniramine maleate, diphenhydramine, diphenhydramine hydrochloride, glycyrrhetinic acid, glycyrrhizin
  • Anti-inflammatory agents such as dipotassium phosphate, monoammonium glycyrrhizinate, allantoin, methyl salicylate; 1-menthol nole, dl-menthol nole, camphor, dl-strengthen, lactic acid menthylate, etc .
  • Moisturizers such as urea, salicylic acid, sodium hyaluronate
  • Bactericides such as isopropylmethyl phenol, quaternary ammonium salts (benzalkonium chloride, benzethonium chloride, etc.), chlorhexidine hydrochlor
  • Examples of the dosage form of the external composition for skin of the present invention include force S that can be prepared into a conventionally known dosage form according to the method of use and application, such as an ointment, lotion, gel, aerosol, and the like. It is done.
  • the external composition for skin of the present invention contains an appropriate amount of a base for obtaining a desired dosage form.
  • a base for example, but not limited to, paraffin, petrolatum, squalane, norafin, white wax, plastibase, polyethylene glycolenore, macrogonole, lauromacronore, silicone oil, silicone, polysorbate, polyoxyethylene hydrogenated castor oil, Oil bases such as olive oil, cottonseed oil, soybean oil, coconut oil; higher alcohols such as cetanol and stearyl alcohol; fatty acid esters (such as isopropyl myristate and sorbitan fatty acid ester), higher fatty acid salt emulsifiers, highly refined egg yolk lecithin , Soybean lecithin, refined soybean lecithin, white beeswax, propylene carbonate, egg yolk phospholipid, egg yolk oil, coconut oil fatty acid, sodium lauryl sulfate, other ionic and nonionic surfactants
  • the composition for external use of the present invention can be prepared by mixing and preparing the above components according to a conventionally known method. Conditions such as temperature in preparation, order of addition of each component, mixing time, etc. should be set as appropriate based on the common general technical knowledge according to the physical or scientific properties of each component, concentration, instrument stress, etc. Is not particularly limited.
  • the external preparation for skin of the present invention comprises For example, it can be prepared by dissolving components soluble in water and alcohol, mixing them and stirring them uniformly, and finally adding BHT.
  • composition for external use of the skin of the present invention can be applied as an antipruritic agent, athlete's foot drug or the like to a place where itching occurs.
  • the application target is not particularly limited as long as it is used for this purpose, but for example, when used as an antipruritic agent, it can be applied to symptom accompanied by itching, insect bite, dry skin, hypersensitive skin, etc. .
  • itch refers to "a feeling that causes the idea of wanting to break through the skin” as described above.
  • an appropriate amount of the external composition for skin of the present invention may be spread over the itchy part of the skin.
  • the solid BHT can physically irritate the itchy part of the skin, replace the itching with a feeling of irritation, and suppress the itching without further rebating.
  • “replacing itching with a sense of irritation” refers to making the skin sensation in a short-term (instantaneous) state of feeling an irritation (feeling itchy) other than “itching”.
  • the skin irritation by the external preparation for skin of the present invention is an appropriate stimulation without damaging the skin, and thus can be used for promoting blood circulation at the application site. Therefore, the external preparation for skin of the present invention can also be used as a massage agent, an external anti-inflammatory analgesic or the like.
  • the obtained external composition for skin was stored at room temperature (about 25 ° C) for 1 week, and its properties were visually confirmed to evaluate the stability. Specifically, dispersibility (presence / absence of particle settling and agglomeration (aggregation of particles)), shape retention (presence / absence of obvious changes compared to initial properties such as viscosity reduction), and particles are solid It was confirmed whether the properties were maintained (softening / dissolution). When there was no change in any of these properties, it was marked as ⁇ , and when any one of the changes was confirmed, it was marked as X.
  • composition for external use with a stability evaluation result of “ ⁇ ” was applied to the affected area of 10 subjects complaining of itching caused by insect bites, etc., and it was easy to apply (one point when it was difficult to apply) 5 points when easy to apply), replacement of itching with irritation (1 point when not replaced with irritation, 5 points when replaced with irritation) and anti-itching effect (when itching does not stop) 1 point and 5 points when itching stops) were evaluated in 5 stages each.
  • composition for external application on skin was applied to the skin of 10 healthy subjects, and with regard to comfortable physical irritation (1 point when not felt, 5 points when felt) Evaluation was performed.
  • Table 1 shows the evaluation results.
  • CVP represents carboxybulle polymer and PG represents propylene glycol.
  • composition for external use with skin containing particles other than BHT (Comparative Examples;! -32) was also evaluated in the same manner. The results are shown in Table 2-1 and Table 2-2 below.
  • CVP represents a carboxybule polymer
  • PG represents propylene glycol
  • Comparative Examples 9 to 13, 16, 25 to 29, and 32 are compositions for external use in skin that contain conventionally known particles. These external preparations for skin were relatively stable and good, but all of them had a replacement effect on the irritating feeling of itchiness and a pleasant stimulating action. In the preparations in which BHT was dissolved, it was not possible to obtain a sensation of itchiness or a pleasant irritation (data not shown).
  • the composition for external use of the skin of the present invention has an excellent anti-itching effect as well as a temporary anti-itching effect of replacing itching with a stimulating feeling. That is, the external composition for skin of the present invention has an immediate and long-lasting itch suppression effect.
  • CVP carboxybutyl polymer
  • PG propylene glycol
  • HPC hydroxypropyl cellulose
  • DPG dipropylene glycol
  • 1,3-BG 1,3-butylene glycol

Abstract

It is intended to provide an external composition for skin capable of imparting a physical feeling of stimulation to the skin, replacing pruritus such as particularly insect bites or hypersensitive skin with a feeling of stimulation, and effectively suppressing pruritus. The external composition for skin is characterized by containing butylhydroxytoluene in a solid state.

Description

明 細 書  Specification
皮膚外用組成物  Skin external composition
技術分野  Technical field
[0001] 本発明は、痒み抑制効果、マッサージ効果等を有する皮膚外用組成物に関する。  [0001] The present invention relates to a composition for external use on skin having an itching suppression effect, a massage effect and the like.
背景技術  Background art
[0002] 皮膚を物理的に刺激することは、血行促進、マッサージ、かゆみの抑制(鎮痒)など の効果があることが知られてレ、る。  [0002] Physically stimulating the skin is known to have effects such as blood circulation promotion, massage, and itching suppression (antipruritus).
[0003] 例えば、美容やリラックス効果を得るためにマッサージなどが行われている力 その 際に、物理的な刺激によるマッサージ効果を発揮するために水不溶性粒子がスクラ ブ剤として配合されている。スクラブ剤としては、ポリエチレンビーズ、タルミ殻粒、結 晶性セルロース等の硬スクラブ剤が汎用されている。硬スクラブ剤は、皮膚上の汚れ を除去する効果や皮膚のマッサージ効果に優れるものの、使用時に不快な皮膚刺 激を感じたり、異物感を感じたりする場合があった。  [0003] For example, the power of performing massage or the like to obtain a beauty or relaxation effect. At that time, water-insoluble particles are blended as a scrub agent in order to exert a massage effect by physical stimulation. As scrubbing agents, hard scrubbing agents such as polyethylene beads, talmi shell grains, and crystalline cellulose are widely used. Although hard scrubs are excellent in removing dirt on the skin and in massaging the skin, there are cases in which unpleasant skin irritation or foreign body sensation is felt during use.
[0004] また、「かゆみ」は、「皮膚を搔破した!/、と!/、う観念を起こさせる感覚」と定義され、概 ね不快となる感覚である。「かゆみ」を伴う症状としては、例えばアトピー性皮膚炎、し つしん、虫さされ、乾燥肌、知覚過敏肌等の多様なものがあり、その病態によって、抗 ヒスタミン剤、局所麻酔剤、保湿剤等が使用されている。し力もながら、それらは、皮 膚内面に浸透し、また科学的なアプローチを伴うものであるため、効力発揮まで時間 を要する。  [0004] In addition, “itch” is defined as “a sensation that causes the skin to break! /, And! /”, And is generally an unpleasant sensation. Symptoms associated with “itch” include various forms such as atopic dermatitis, urticaria, insect bites, dry skin, and hypersensitive skin. Depending on the condition, antihistamines, local anesthetics, moisturizing Agents are used. However, since they penetrate into the inner surface of the skin and involve a scientific approach, it takes time to take effect.
[0005] この様な背景から、かゆみを短時間で効果的に抑制し得る皮膚外用組成物が求め られていた。かゆみを抑制する目的で使用される皮膚外用剤は、従来から数多く知ら れており、例えば、特許文献 1には天然油脂と抗酸化剤を配合した皮膚外用剤が開 示されている。このような皮膚外用剤中には、保存剤、安定化剤、抗酸化剤等として 一般的にブチルヒドロキシトルエンが 0. 0;!〜 1 %程度配合されている。しかしながら 、これらの外用剤についても皮膚を刺激することを目的としたものではなぐ効果的に 鎮痒することができな力 た。  [0005] Against this background, there has been a demand for an external composition for skin that can effectively suppress itching in a short time. Many external preparations for skin used for the purpose of suppressing itching have been known. For example, Patent Document 1 discloses an external preparation for skin containing natural oils and fats and antioxidants. In such external preparations for skin, butylhydroxytoluene is generally added in an amount of about 0.0 ;! to 1% as a preservative, stabilizer, antioxidant and the like. However, these external preparations have also been unable to effectively suppress the skin rather than those intended to irritate the skin.
特許文献 1 :特開 2000— 159678 発明の開示 Patent Document 1: JP 2000-159678 Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0006] 本発明は、塗布によって皮膚刺激を与え、快適なマッサージ効果を発揮する皮膚 外用剤を提供することを主な目的とする。また、本発明は、虫さされ、知覚過敏肌等 のかゆみを刺激感に置換し、さらに効果的にかゆみを抑制することが可能な皮膚外 用組成物を提供することを主な目的とするものである。 [0006] The main object of the present invention is to provide an external preparation for skin that gives skin irritation by application and exhibits a comfortable massage effect. Another object of the present invention is to provide an external composition for skin, which can replace itching caused by insects and hypersensitivity skin with irritation, and can effectively suppress itching. Is.
課題を解決するための手段  Means for solving the problem
[0007] 本発明者は、上記課題を解決すべく鋭意検討を重ねた結果、プチルヒドロキシトノレ ェン(以下 BHTと略記することがある)を固体状態で外用剤に配合し、これを皮膚に 適用することによって、マッサージ効果ゃ鎮痒効果が得られることを見出した。 BHT は化粧品等の外用剤に広く用いられる成分であるが、専ら酸化防止、安定化等を期 待して配合される成分であり、マッサージや鎮痒等を目的として用いることは全く想起 されていな力、つた。本発明は、このような知見に基づき、さらに研究を重ねた結果、完 成されたものである。  [0007] As a result of intensive studies to solve the above-mentioned problems, the present inventor formulated ptylhydroxytonolene (hereinafter sometimes abbreviated as BHT) into an external preparation in a solid state, and this was applied to the skin. It has been found that a massage effect can be obtained by applying it. BHT is a component that is widely used in external preparations such as cosmetics, but it is a component that is formulated exclusively for anti-oxidation, stabilization, etc., and it has never been recalled for use for purposes such as massage or wrinkles. Power, ivy. The present invention has been completed as a result of further research based on such knowledge.
[0008] 本発明は、以下の皮膚外用組成物を提供する。  [0008] The present invention provides the following external composition for skin.
項 1. 固体状態のプチルヒドロキシトルエン (以下、 BHTと示す)を含有することを特 徴とする皮膚外用組成物。  Item 1. A composition for external use on skin, characterized by containing solid-state butylhydroxytoluene (hereinafter referred to as BHT).
項 2· BHTの粒子径が 1000 m以下であることを特徴とする項 1に記載の皮膚外用 組成物。  Item 2. The external composition for skin according to Item 1, wherein the particle size of BHT is 1000 m or less.
項 3.粒子径 350 未満の BHT、粒子径 350〜500 の BHT、粒子径 50;!〜 1 000 mの BHTを 1種又は 2種以上組み合わせて配合することを特徴とする項 1又 は 2に記載の皮膚外用組成物。  Item 3. A BHT having a particle size of less than 350, a BHT having a particle size of 350 to 500, a particle size of 50;! To 1 000 m, or a combination of two or more BHTs. The composition for external application to skin.
項 4· BHTの含有量が 10〜40重量%である項 1〜3のいずれかに記載の皮膚外用 組成物。  Item 4. The composition for external application to skin according to any one of Items 1 to 3, wherein the BHT content is 10 to 40% by weight.
項 5.さらに水溶性高分子を含有する、項 1〜4のいずれかに記載の皮膚外用組成 物。  Item 5. The external composition for skin according to any one of Items 1 to 4, further comprising a water-soluble polymer.
発明の効果 [0009] 本発明の皮膚外用組成物は、直接皮膚に適用するものであり、固体状態の BHT が皮膚を物理的に刺激することによって皮膚に適度なマッサージ刺激を与えることが できる。また、本発明の皮膚外用組成物を、かゆみを有する患部に適用すると、固体 状態の BHTの物理的な刺激によって、短時間でかゆみを刺激感に置換することが でき、かゆみを効果的に抑制することができる。 The invention's effect [0009] The external composition for skin according to the present invention is applied directly to the skin, and the BHT in a solid state physically stimulates the skin, so that an appropriate massage stimulus can be given to the skin. In addition, when the composition for external use of the skin of the present invention is applied to an affected area having itching, it can be replaced with a feeling of irritation in a short time by physical stimulation of BHT in a solid state, and the itching is effectively suppressed. can do.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0010] 本発明の皮膚外用組成物は、 BHTを固体状態で含有することを主な特徴としてい る。以下、本発明の皮膚外用組成物の各成分、製造方法、適用等について説明する[0010] The composition for external use of the skin of the present invention is characterized mainly by containing BHT in a solid state. Hereinafter, each component, manufacturing method, application, etc. of the composition for external use of the present invention will be described.
〇 本発明の鎮痒剤は、 BHTを必須の成分として含有する。プチルヒドロキシトルエン は、白色結晶の形状を有する化合物であり、ジブチルヒドロキシトルエンとも呼ばれる 1S 両者は同じ化合物([ (CH ) C] C H (CH ) OH)を指す。 BHTは、従来、化粧 * The antipruritic agent of this invention contains BHT as an essential component. Ptylhydroxytoluene is a compound having a white crystal shape, and both 1S, also called dibutylhydroxytoluene, refer to the same compound ([(CH 3) C] C H (CH 2) OH). BHT, traditionally makeup
3 3 2 6 2 3  3 3 2 6 2 3
料、医薬品、食品等の酸化防止剤、安定化剤等の用途で配合されている。  It is blended for uses such as antioxidants and stabilizers for foods, pharmaceuticals, foods and the like.
[0011] BHTとしては、商業的に入手可能なものを用いることができ、例えば、プチルヒドロ キシトルエン(三栄化工株式会社)、ジブチルヒドロキシトルエン (イーストマン ケミカ ノレ ジャパン株式会社、上野製薬株式会社、株式会社エーピーアイコーポレーション 、住友化学工業株式会社、長瀬産業株式会社、 日揮ユニバーサル株式会社、三菱 ゥエルファーマ株式会社)等が挙げられる。 [0011] As BHT, commercially available ones can be used. For example, butyl hydroxytoluene (Sanei Chemical Co., Ltd.), dibutylhydroxytoluene (Eastman Chemica Norre Japan Co., Ltd., Ueno Pharmaceutical Co., Ltd.) API Corporation, Sumitomo Chemical Co., Ltd., Nagase Sangyo Co., Ltd., JGC Universal Co., Ltd., Mitsubishi Wel Pharma Co., Ltd.).
[0012] 本発明に使用される BHTの粒子径は、 lOOO ^ m以下程度であり、好ましくは 100 0〜50〃 111程度、より好ましくは 1000〜; 100〃 m程度、さらに好ましくは 1000〜; 180 in程度である。ここで、各粒子径を有する BHTは、 BHTを乳鉢などで粉砕した後 、各径を有する篩等に供することで得ることができる。  [0012] The particle size of BHT used in the present invention is about lOOOO ^ m or less, preferably about 1000 to 50 to 111, more preferably about 1000 to; about 100 to m, more preferably about 1000 to; About 180 in. Here, BHT having each particle diameter can be obtained by pulverizing BHT with a mortar or the like and then applying it to a sieve having each diameter.
[0013] また、本発明においては異なる粒子径を有する BHTを組み合わせて用いることに よって、より優れた効果が得られることから、 2種以上の粒子径を有する BHTを組み 合わせて配合することが望ましぐ例えば、粒子径 350 111未満の BHT、粒子径 35 0—500 ^ HK BHT,粒子径 50;!〜 1000 mの BHTを 2種以上組み合わせて用 いること力 Sできる。好ましい組み合わせとしては、例えば、(a) 501〜; 1000 m程度 の粒子径を有する BHT及び 350〜500 μ m程度の粒子径を有する ΒΗΤの組み合 わせ;(b) 350 [I m未満程度の粒子径を有する BHT及び 350〜500 μ m程度の粒 子径を有する BHTの組み合わせ等が挙げられる。 [0013] Further, in the present invention, by using a combination of BHTs having different particle sizes, a more excellent effect can be obtained. Therefore, it is possible to combine BHTs having two or more types of particle sizes in combination. Desirably, for example, BHT having a particle size of less than 350 111, particle size of 350-500 ^ HK BHT, particle size of 50;! Preferred combinations include, for example, (a) 501-; about 1000 m A combination of BHT with a particle size of and ΒΗΤ having a particle size of about 350 to 500 μm; (b) BHT with a particle size of less than 350 [Im and a particle size of about 350 to 500 μm A combination of BHT having
[0014] 2種以上の粒子径を有する BHTを組み合わせて用いる場合、各粒子径を有する B HTの配合割合は、痒みの刺激感への置換作用を発揮し得る範囲であれば適宜設 定すること力できる力 例えば、上記(a)の組み合わせであれば、 350〜500 111程 度の粒子径を有する BHT1重量部とした場合、 501〜; 1000 m程度の粒子径を有 する BHTを 0. ;!〜 10重量部程度、好ましくは 0. 25-7. 5重量部程度、より好ましく は 0· 5〜5重量部程度;上記(b)の組み合わせであれば、 350〜500 111程度の粒 子径を有する BHT1重量部とした場合、 350 m未満程度の粒子径を有する BHT を、 0. ;!〜 10重量部程度、好ましくは 0. 25-7. 5重量部程度、より好ましくは 0. 5 〜 5重量部程度の割合で組み合わせて用いる。  [0014] When two or more types of BHT having a particle size are used in combination, the blending ratio of BHT having each particle size is appropriately set as long as the substitution effect on the irritating feeling of itchiness can be exhibited. For example, in the case of the combination (a) above, when 1 part by weight of BHT having a particle size of about 350 to 500 111 is used, BHT having a particle size of about 501 to 1000 m is set to 0. About 10 to 10 parts by weight, preferably about 0.25 to 7-5 parts by weight, more preferably about 0.5 to 5 parts by weight; with the combination (b) above, about 350 to 500 111 grains In the case of 1 part by weight of BHT having a child diameter, BHT having a particle diameter of less than 350 m is about 0.;! To about 10 parts by weight, preferably about 0.25-7. 5 parts by weight, more preferably 0. Used in combination at a ratio of about 5 to 5 parts by weight.
[0015] 本発明の限定的解釈を望むものではないが、粒子径が不均一な BHTを配合する ことによって、より顕著に本発明の効果が奏され得る。  [0015] Although a limited interpretation of the present invention is not desired, the effects of the present invention can be more remarkably achieved by blending BHT having a non-uniform particle size.
[0016] 本発明の皮膚外用組成物における BHTの配合量は、 10〜40重量%程度、好まし くは 15〜35重量%程度、より好ましくは 20〜30重量%程度である。このような配合 量であれば、製剤としての安定性を保ちつつ、皮膚刺激によるマッサージ効果ゃ鎮 痒効果がより顕著に発揮され得る。  [0016] The amount of BHT in the external composition for skin of the present invention is about 10 to 40% by weight, preferably about 15 to 35% by weight, more preferably about 20 to 30% by weight. With such a blending amount, the massage effect and the antipruritic effect due to skin irritation can be exhibited more significantly while maintaining the stability as a preparation.
[0017] (2)その他の成分  [0017] (2) Other ingredients
本発明の皮膚外用組成物には、前記 BHTの他、アルコールが含有されることが好 ましい。アルコールを配合することで、固体状態の BHTを好適に分散させることがで き、皮膚を満遍なぐかつ適度に刺激することが可能となる。本発明において使用さ れるアルコールとしては、化粧料、医薬品の分野において一般的に使用されているも のであれば特に限定されないが、例えば、メタノール、エタノール、プロパノール、イソ プロパノール、ブタノール、イソブタノール等の炭素数 1〜6、好ましくは炭素数 1〜3 の低級アルコール;プロピレングリコール、ジプロピレングリコール、グリセリン、 1 , 3— ブチレングリコール、ブチレングリコール、濃グリセリン、ポリエチレングリコール、マル チトール、マンニトール、ソルビトール等の多価アルコールなどが例示される。これら を 1種単独で使用してもよぐ 2種以上を組み合わせて用いてもよい。また、低級アル コールは、無水、含水の別を問わない。本発明においては、(含水)エタノール、無水 エタノール、イソプロパノールを用いることが好まし!/、。 The composition for external use of the present invention preferably contains alcohol in addition to the BHT. By blending alcohol, solid-state BHT can be dispersed favorably, and the skin can be uniformly and moderately stimulated. The alcohol used in the present invention is not particularly limited as long as it is commonly used in the fields of cosmetics and pharmaceuticals. For example, methanol, ethanol, propanol, isopropanol, butanol, isobutanol and the like are used. Lower alcohol having 1 to 6 carbon atoms, preferably 1 to 3 carbon atoms; propylene glycol, dipropylene glycol, glycerin, 1,3-butylene glycol, butylene glycol, concentrated glycerin, polyethylene glycol, maltitol, mannitol, sorbitol, etc. Examples include polyhydric alcohols. these May be used alone or in combination of two or more. The lower alcohol may be anhydrous or hydrated. In the present invention, it is preferable to use (hydrous) ethanol, absolute ethanol, or isopropanol!
[0018] 本発明の皮膚外用組成物におけるアルコールの配合量は、 0〜45重量%程度、 好ましくは 4〜40重量%程度、より好ましくは 4〜35重量%程度である。  [0018] The blending amount of alcohol in the composition for external use of the present invention is about 0 to 45% by weight, preferably about 4 to 40% by weight, more preferably about 4 to 35% by weight.
[0019] 本発明の皮膚外用組成物における BHTとアルコールの配合比率は、 BHTを 1重 量部とした場合、アルコールが約 3重量部以下、好ましくは約 2重量部以下、より好ま しくは約 1重量部以下である。このような配合比率であれば、 BHTの固体状態を維持 することができ、かつ適度な刺激を皮膚に与えることができる。  The blending ratio of BHT and alcohol in the external composition for skin of the present invention is such that when BHT is 1 part by weight, alcohol is about 3 parts by weight or less, preferably about 2 parts by weight or less, and more preferably about 1 part by weight or less. With such a blending ratio, the solid state of BHT can be maintained and an appropriate stimulus can be given to the skin.
[0020] 本発明の皮膚外用組成物には、必要に応じて水、水溶性高分子等を配合してもよ い。水溶性高分子としては、従来公知のものを使用することができる力 例えばカル ボキシビニノレポリマー、ポリビニルアルコール、ポリビニルメチルエーテル、ポリビニノレ キシェチルセルロース、プルラン、寒天、ゼラチン、アルギン酸及びその塩、カラギー ナン、ガム類等が挙げられる。これらを 1種単独で使用してもよぐ 2種以上を組み合 わせて用いてもよい。  [0020] The external composition for skin of the present invention may contain water, a water-soluble polymer, or the like, if necessary. Conventionally known water-soluble polymers can be used, for example, carboxyvininole polymer, polyvinyl alcohol, polyvinyl methyl ether, polyvinylinoxychetyl cellulose, pullulan, agar, gelatin, alginic acid and its salts, carrageen Examples include naan and gums. These may be used alone or in combination of two or more.
[0021] 本発明の皮膚外用組成物における水の配合量は、 25〜89. 5重量%程度、好まし くは 27〜80. 2重量%程度、より好ましくは 28〜75重量%程度;水溶性高分子の配 合量は、 0. 5〜5重量%程度、好ましくは 0. 8〜4重量%程度、より好ましくは 1〜3 重量%程度である。  [0021] The amount of water in the external composition for skin of the present invention is about 25 to 89.5% by weight, preferably about 27 to 80.2% by weight, more preferably about 28 to 75% by weight; The amount of the conductive polymer to be combined is about 0.5 to 5% by weight, preferably about 0.8 to 4% by weight, and more preferably about 1 to 3% by weight.
[0022] 本発明の典型的な処方例としては、 BHTを 10〜40重量0 /0、ァノレコーノレを 0〜45 重量%、水溶性高分子を 0. 5〜5重量%、水 25〜89. 5重量%含有する皮膚外用 組成物が例示される。 [0022] Typical formulation examples of the present invention, 10 to 40 weight BHT 0/0, the Anorekonore 0-45 wt%, a water-soluble polymer 0.5 to 5% by weight, water 25-89. A composition for external use containing 5% by weight is exemplified.
[0023] 本発明の皮膚外用組成物には、上記以外にも必要に応じて、化粧料、医薬部外品 、医薬品に一般的に用いられる各種成分、水性成分、油性成分、保湿成分、賦形剤 、増粘剤、防腐剤、酸化防止剤、 pH調整剤、担体、香料、色剤、薬剤等を単独又は 2種以上を混合と組み合わせて各種剤型に調製することもできる。また、本発明の皮 膚外用組成物には、本発明の効果を損なわない範囲内で、公知の局所麻酔剤、消 炎剤等を含んでもよぐ例えば、リドカイン、ジブ力イン、塩酸ジブ力イン、ジフェンヒド ラミン、ァミノ安息香酸ェチル、デシットテシチン等の局所麻酔剤;マレイン酸クロルフ ェニラミン、ジフェンヒドラミン、塩酸ジフェンヒドラミン、グリチルレチン酸、グリチルリチ ン酸ニカリウム、グリチルリチン酸モノアンモニゥム、アラントイン、サリチル酸メチル等 の消炎剤; 1ーメントーノレ、 dl—メントーノレ、カンフル、 dl—力ンフノレ、乳酸メンチル等の 清涼化剤;尿素、サリチル酸、ヒアルロン酸ナトリウム等の保湿剤;イソプロピルメチル フエノール、第四級アンモニゥム塩 (塩化ベンザルコニゥム、塩化べンゼトニゥムなど) 、塩酸クロルへキシジン、スルフアジアジン等の殺菌剤;硝酸ォキシコナゾール、塩酸 ブテナフィン、塩酸ァモロルフイン、塩酸テルビナフイン、ラノコナゾール等の抗真菌 剤;トウガラシチンキ、カブサイシン等の温熱成分等が挙げられる。 [0023] In addition to the above, the composition for external use of the skin of the present invention includes various components generally used in cosmetics, quasi-drugs, pharmaceuticals, aqueous components, oil-based components, moisturizing components, moisturizing components, and so on. Forms, thickeners, preservatives, antioxidants, pH adjusters, carriers, fragrances, colorants, drugs and the like can be prepared in various dosage forms alone or in combination of two or more. In addition, the composition for external use of the skin of the present invention includes a known local anesthetic and antibacterial agent within the range not impairing the effects of the present invention. For example, local anesthetics such as lidocaine, dibu force in, dibu force in hydrochloride, diphenhydramine, ethyl aminobenzoate, desitthecin; chlorpheniramine maleate, diphenhydramine, diphenhydramine hydrochloride, glycyrrhetinic acid, glycyrrhizin Anti-inflammatory agents such as dipotassium phosphate, monoammonium glycyrrhizinate, allantoin, methyl salicylate; 1-menthol nole, dl-menthol nole, camphor, dl-strengthen, lactic acid menthylate, etc .; Moisturizers such as urea, salicylic acid, sodium hyaluronate Bactericides such as isopropylmethyl phenol, quaternary ammonium salts (benzalkonium chloride, benzethonium chloride, etc.), chlorhexidine hydrochloride, sulfadiazine, etc .; oxyconazole nitrate, butenaf hydrochloride Emissions, hydrochloric Amororufuin, hydrochloric Terubinafuin, antifungal agents such as lanoconazole; capsicum tincture, and the like thermal components such Kabusaishin.
[0024] 本発明の皮膚外用組成物の剤型としては、使用方法や適用部分に従って従来公 知の剤型に調製することができる力 S、例えば、軟膏、ローション、ゲル、エアゾール剤 等が挙げられる。 [0024] Examples of the dosage form of the external composition for skin of the present invention include force S that can be prepared into a conventionally known dosage form according to the method of use and application, such as an ointment, lotion, gel, aerosol, and the like. It is done.
[0025] 本発明の皮膚外用組成物には、所望の剤型とするための基剤が適当量含有される 。例えば、これに限られるものではないが、パラフィン、ワセリン、スクヮラン、ノ ラフィン 、 白ロウ、プラスチベース、ポリエチレングリコーノレ、マクロゴーノレ、ラウロマクロゴーノレ 、シリコン油、シリコン、ポリソルベート、ポリオキシエチレン硬化ヒマシ油、ォリーブ油 、綿実油、大豆油、ヤシ油などの油系基剤;セタノール、ステアリルアルコールなどの 高級アルコール;脂肪酸エステル (ミリスチン酸イソプロピル、ソルビタン脂肪酸エステ ルなど)、高級脂肪酸塩型乳化剤、高度精製卵黄レシチン、大豆レシチン、精製大 豆レシチン、サラシミツロウ、プロピレンカーボネート、卵黄リン脂質、卵黄油、ヤシ油 脂肪酸、ラウリル硫酸ナトリウム、その他イオン性、非イオン性界面活性剤などの乳化 剤;リン酸、酢酸、塩酸、水酸化ナトリウムなどの pH調整剤;液化石油ガス、ジメチノレ エーテルなどの噴射剤などが挙げられる。  [0025] The external composition for skin of the present invention contains an appropriate amount of a base for obtaining a desired dosage form. For example, but not limited to, paraffin, petrolatum, squalane, norafin, white wax, plastibase, polyethylene glycolenore, macrogonole, lauromacronore, silicone oil, silicone, polysorbate, polyoxyethylene hydrogenated castor oil, Oil bases such as olive oil, cottonseed oil, soybean oil, coconut oil; higher alcohols such as cetanol and stearyl alcohol; fatty acid esters (such as isopropyl myristate and sorbitan fatty acid ester), higher fatty acid salt emulsifiers, highly refined egg yolk lecithin , Soybean lecithin, refined soybean lecithin, white beeswax, propylene carbonate, egg yolk phospholipid, egg yolk oil, coconut oil fatty acid, sodium lauryl sulfate, other ionic and nonionic surfactants, etc .; phosphoric acid, acetic acid, salt PH adjusting agents such as acid and sodium hydroxide; propellants such as liquefied petroleum gas and dimethylol ether.
[0026] 本発明の皮膚外用組成物は、以上の成分を従来公知の方法に従って混合し、調 製すること力 Sできる。調製における温度、各成分の添加の順番、混合時間等の条件 は、各成分の物理的又は科学的性質、濃度、機器の応力等に応じ、当該分野の技 術常識に基づいて適宜設定することが特に限定されない。本発明の皮膚外用剤は、 例えば、水とアルコールそれぞれに溶解性の成分を溶解し、それらを混合、一様に 攪拌したものに、 BHTを最後に加えることにより調製することができる。 [0026] The composition for external use of the present invention can be prepared by mixing and preparing the above components according to a conventionally known method. Conditions such as temperature in preparation, order of addition of each component, mixing time, etc. should be set as appropriate based on the common general technical knowledge according to the physical or scientific properties of each component, concentration, instrument stress, etc. Is not particularly limited. The external preparation for skin of the present invention comprises For example, it can be prepared by dissolving components soluble in water and alcohol, mixing them and stirring them uniformly, and finally adding BHT.
[0027] 本発明の皮膚外用組成物は、鎮痒剤、水虫薬等として、かゆみを生じる箇所に適 用することが可能である。この目的において使用されるのであれば適用対象は特に 限定されないが、例えば、鎮痒剤として用いる場合、しっしん、虫さされ、乾燥肌、知 覚過敏肌等のかゆみを伴う症状に適用することができる。  [0027] The composition for external use of the skin of the present invention can be applied as an antipruritic agent, athlete's foot drug or the like to a place where itching occurs. The application target is not particularly limited as long as it is used for this purpose, but for example, when used as an antipruritic agent, it can be applied to symptom accompanied by itching, insect bite, dry skin, hypersensitive skin, etc. .
[0028] 本発明において「かゆみ」とは、前述のように「皮膚を搔破したいという観念を起こさ せる感覚」を指す。  [0028] In the present invention, "itch" refers to "a feeling that causes the idea of wanting to break through the skin" as described above.
[0029] 本発明の皮膚外用組成物を前記のかゆみの軽減を目的として使用する場合は、皮 膚のかゆい部分に本発明の皮膚外用組成物の適量を塗り広げればよい。塗り広げる ことによって、固体状態の BHTが皮膚のかゆい部分を物理的に刺激し、かゆみを刺 激感に置換し、更にぶりかえすことなくかゆみを抑制することができる。ここで、「かゆ みを刺激感に置換する」とは、短期的(瞬間的に)に皮膚感覚を「かゆみ」以外の刺 激 (搔いた感じ)を感じる状態にすることを指す。  [0029] When the external composition for skin of the present invention is used for the purpose of reducing the itching, an appropriate amount of the external composition for skin of the present invention may be spread over the itchy part of the skin. By spreading the coating, the solid BHT can physically irritate the itchy part of the skin, replace the itching with a feeling of irritation, and suppress the itching without further rebating. Here, “replacing itching with a sense of irritation” refers to making the skin sensation in a short-term (instantaneous) state of feeling an irritation (feeling itchy) other than “itching”.
[0030] また、本発明の皮膚外用剤による皮膚刺激は、皮膚を傷つけることなぐ適度な刺 激であるため、適用箇所の血行を促進するためなどに用いることが可能である。従つ て、本発明の皮膚外用剤は、マッサージ剤、外用消炎鎮痛剤等として用いることもで きる。  [0030] Further, the skin irritation by the external preparation for skin of the present invention is an appropriate stimulation without damaging the skin, and thus can be used for promoting blood circulation at the application site. Therefore, the external preparation for skin of the present invention can also be used as a massage agent, an external anti-inflammatory analgesic or the like.
実施例  Example
[0031] 以下に実施例等を示して本発明をより詳細に説明するが、本発明はこれらに限定さ れなレ、。  [0031] Hereinafter, the present invention will be described in more detail with reference to Examples and the like, but the present invention is not limited thereto.
[0032] 下記表 1に示される処方に基づいて各種成分を配合し、皮膚外用組成物を得た。  [0032] Based on the formulation shown in Table 1 below, various components were blended to obtain an external composition for skin.
表 1に規定される分量の水を一部採取し、そこにカルボキシビュルポリマーを攪拌し ながら徐々に添加した。これとは別に、表 1に規定される分量のアルコールの一部に 、 BHT (プチルヒドロキシトルエン:三栄化工株式会社)及び pH調整剤(トリエタノー ルァミン)以外の成分を加え、攪拌混合した。この溶液を、前記カルボキシビュルポリ マーを混合した水溶液に、攪拌しながら徐々に添加した。 pH調整剤(トリエタノール ァミン)を添加する場合は、水残部に pH調整剤を混合したものをさらに加えた。得ら れた溶液を一定時間攪拌し、最後に BHTを加えてさらに攪拌し、皮膚外用組成物を 調製した。ここで、 BHTは、乳鉢中で粉砕し、各径を有する篩で分類したものを用い た。 A portion of the amount of water specified in Table 1 was sampled, and the carboxybule polymer was gradually added thereto with stirring. Separately, components other than BHT (Ptylhydroxytoluene: Sanei Chemical Co., Ltd.) and a pH adjuster (triethanolamine) were added to a part of the amount of alcohol specified in Table 1 and mixed with stirring. This solution was gradually added to the aqueous solution mixed with the carboxybutyl polymer while stirring. When adding a pH adjuster (triethanolamine), a mixture of the pH adjuster and the remaining water was further added. Obtained The resulting solution was stirred for a certain time, and finally BHT was added and further stirred to prepare a composition for external use on the skin. Here, BHT used was crushed in a mortar and classified by a sieve having each diameter.
[0033] 得られた皮膚外用組成物を常温 (約 25°C)にて 1週間保存した後、その性状を目視 により確認し、安定性を評価した。具体的には、分散性 (粒子の沈降や団粒化 (粒子 の凝集)の有無)、保型性 (粘度低下等の初期性状と比較した場合の明らかな変化の 有無)、粒子が固体の性状を維持しているかどうか (軟化、溶解の有無)について確 認した。これらの性状のいずれにも変化が無かった場合は〇とし、いずれか 1つでも 変化が確認された場合は Xとした。  [0033] The obtained external composition for skin was stored at room temperature (about 25 ° C) for 1 week, and its properties were visually confirmed to evaluate the stability. Specifically, dispersibility (presence / absence of particle settling and agglomeration (aggregation of particles)), shape retention (presence / absence of obvious changes compared to initial properties such as viscosity reduction), and particles are solid It was confirmed whether the properties were maintained (softening / dissolution). When there was no change in any of these properties, it was marked as ◯, and when any one of the changes was confirmed, it was marked as X.
[0034] また、安定性の評価結果が「〇」の皮膚外用組成物を、虫さされ等によるかゆみを 訴える被験者 10名の患部に塗布し、適用しやすさ(塗布しにくい場合を 1点、塗布し やすい場合を 5点)、かゆみの刺激感への置換 (刺激感に置換されない場合を 1点、 刺激感に置換された場合を 5点)および痒み止め効果 (かゆみが止まらなかった場合 を 1点、かゆみが止まった場合を 5点)に関し、各々 5段階で評価を行った。  [0034] In addition, the composition for external use with a stability evaluation result of “◯” was applied to the affected area of 10 subjects complaining of itching caused by insect bites, etc., and it was easy to apply (one point when it was difficult to apply) 5 points when easy to apply), replacement of itching with irritation (1 point when not replaced with irritation, 5 points when replaced with irritation) and anti-itching effect (when itching does not stop) 1 point and 5 points when itching stops) were evaluated in 5 stages each.
[0035] さらに、得られた皮膚外用組成物を健常者 10名の皮膚に塗布し、快適な物理的刺 激感 (感じない場合を 1点、感じた場合を 5点)に関し、 5段階で評価を行った。  [0035] Furthermore, the obtained composition for external application on skin was applied to the skin of 10 healthy subjects, and with regard to comfortable physical irritation (1 point when not felt, 5 points when felt) Evaluation was performed.
[0036] 各被験者による評点を合計し、合計点が 45〜50点:◎、 35〜45点:〇、 25〜35 点;△、 25点未満: Xとした。  [0036] The scores by each subject were totaled, and the total score was 45-50 points: ◎, 35-45 points: ◯, 25-35 points; Δ, less than 25 points: X.
[0037] これらの評価結果を表 1に示す。表中、 CVPはカルボキシビュルポリマー、 PGはプ ロピレングリコールを表す。  [0037] Table 1 shows the evaluation results. In the table, CVP represents carboxybulle polymer and PG represents propylene glycol.
[0038] [表 1] [0038] [Table 1]
Figure imgf000010_0001
Figure imgf000010_0001
[0039] また、 BHT以外の粒子を配合した皮膚外用組成物(比較例;!〜 32)についても同 様に評価した。結果を下記表 2— 1及び表 2— 2に示す。 [0039] In addition, the composition for external use with skin containing particles other than BHT (Comparative Examples;! -32) was also evaluated in the same manner. The results are shown in Table 2-1 and Table 2-2 below.
[0040] 表中、 CVPはカルボキシビュルポリマー、 PGはプロピレングリコールを表す。 [0040] In the table, CVP represents a carboxybule polymer, and PG represents propylene glycol.
[0041] [表 2-1] [0041] [Table 2-1]
Figure imgf000012_0001
Figure imgf000012_0001
[0042] [表 2-2] [0042] [Table 2-2]
Figure imgf000014_0001
Figure imgf000014_0001
[0043] 表中、比較例;!〜 8、 14、 15、 17-24, 30及び 31は、組成物の安定性が悪く評価 できなかった。 [0043] In the table, Comparative Examples;! To 8, 14, 15, 17-24, 30 and 31 could not be evaluated due to poor stability of the compositions.
[0044] 比較例 9〜13、 16、 25〜29及び 32は、従来公知の粒子を配合した皮膚外用組成 物である。これらの皮膚外用剤は、比較的安定性は良力、つたものの、いずれも痒み の刺激感への置換作用および快適な刺激作用を有してレ、なレ、ことが示された。なお 、 BHTを溶解状態とした製剤では、痒みの刺激感への置換および快適な刺激感は 得られなかった(データ示さず)。  [0044] Comparative Examples 9 to 13, 16, 25 to 29, and 32 are compositions for external use in skin that contain conventionally known particles. These external preparations for skin were relatively stable and good, but all of them had a replacement effect on the irritating feeling of itchiness and a pleasant stimulating action. In the preparations in which BHT was dissolved, it was not possible to obtain a sensation of itchiness or a pleasant irritation (data not shown).
[0045] 一方、実施例;!〜 19の皮膚外用組成物は、いずれも安定性、皮膚への適用のしゃ すさに優れていることが示された。また、固体状態の BHTが配合されていることから、 皮膚に塗布することによって快適な刺激感を得られるものであり、かゆみ抑制効果、 かゆみを刺激感に置換する作用をも備えた皮膚外用剤であることが示された。特に 粒子径の異なる BHTを組み合わせて用いることにより、より優れた快適な刺激感、か ゆみ止め効果、かゆみを刺激感に置換する作用を発揮することが示された。  [0045] On the other hand, it was shown that all of the compositions for external use of skin in Examples;! To 19 were excellent in stability and softness to application to the skin. In addition, because it contains BHT in a solid state, it can provide a comfortable irritation feeling when applied to the skin, and it also has an anti-itching effect and an action to replace itching with irritation. It was shown that. In particular, it was shown that the combination of BHT with different particle sizes exerted a more comfortable and comfortable irritation, anti-itching effect, and the action of replacing itching with irritation.
[0046] かゆみは、物理的な刺激が加われば、かえって増強されることが知られている。しか しながら、本発明の皮膚外用組成物は、かゆみを刺激感に置換するという一時的な かゆみ抑制効果のみならず、優れたかゆみ止め効果を有することが示された。すな わち、本発明の皮膚外用組成物は、即効性かつ持続性のあるかゆみ抑制効果を有 するものである。  [0046] Itching is known that itching is enhanced when a physical stimulus is applied. However, it was shown that the composition for external use of the skin of the present invention has an excellent anti-itching effect as well as a temporary anti-itching effect of replacing itching with a stimulating feeling. That is, the external composition for skin of the present invention has an immediate and long-lasting itch suppression effect.
[0047] 以下に処方例を示す。表中、 CVPはカルボキシビュルポリマー、 PGはプロピレン グリコール、 HPCはヒドロキシプロピルセルロース、 DPGはジプロピレングリコール、 1 , 3— BGは 1 , 3—ブチレングリコールを表す。  [0047] Formulation examples are shown below. In the table, CVP represents carboxybutyl polymer, PG represents propylene glycol, HPC represents hydroxypropyl cellulose, DPG represents dipropylene glycol, and 1,3-BG represents 1,3-butylene glycol.
[0048] [表 3-1] 〔〕 D¾¾00934I [0048] [Table 3-1] [] D¾¾00934I
Figure imgf000016_0001
Figure imgf000016_0001
Figure imgf000017_0001
Figure imgf000017_0001

Claims

請求の範囲 The scope of the claims
[1] 固体状態のプチルヒドロキシトルエン (以下、 BHTと示す)を含有することを特徴と する皮膚外用組成物。  [1] A composition for external use on skin, characterized by containing solid-state butyl hydroxytoluene (hereinafter referred to as BHT).
[2] BHTの粒子径が 1000 m以下であることを特徴とする請求項 1に記載の皮膚外 用組成物。  [2] The external composition for skin according to claim 1, wherein the particle size of BHT is 1000 m or less.
[3] 粒子径 350 111未満の BH丁、粒子径 350〜500 mの BH丁、粒子径 501〜; 100 [3] BH D with a particle size of less than 350 111, BH D with a particle size of 350-500 m, Particle size 501-;
0 mの BHTを 1種又は 2種以上組み合わせて配合することを特徴とする請求項 1又 は 2に記載の皮膚外用組成物。 The external composition for skin according to claim 1 or 2, wherein 0 m of BHT is used alone or in combination of two or more.
[4] BHTの含有量が 10〜40重量%である請求項 1〜3のいずれかに記載の皮膚外用 組成物。  [4] The external composition for skin according to any one of claims 1 to 3, wherein the BHT content is 10 to 40% by weight.
[5] さらに水溶性高分子を含有する、請求項 1〜4のいずれかに記載の皮膚外用組成 物。  [5] The external composition for skin according to any one of claims 1 to 4, further comprising a water-soluble polymer.
PCT/JP2007/069111 2006-09-29 2007-09-28 External composition for skin WO2008038807A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006270076A JP5063072B2 (en) 2006-09-29 2006-09-29 Skin external composition
JP2006-270076 2006-09-29

Publications (1)

Publication Number Publication Date
WO2008038807A1 true WO2008038807A1 (en) 2008-04-03

Family

ID=39230237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/069111 WO2008038807A1 (en) 2006-09-29 2007-09-28 External composition for skin

Country Status (2)

Country Link
JP (1) JP5063072B2 (en)
WO (1) WO2008038807A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2493955A (en) * 2011-08-25 2013-02-27 Hds Ltd Methods and compositions for reducing allergic reactions to fragranced products and perfumes
WO2021204568A1 (en) 2020-04-07 2021-10-14 Universität Basel A topical composition for treatment of pruritus

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126158A (en) * 1993-10-27 1995-05-16 Taisho Pharmaceut Co Ltd Crotamiton-blended external preparation
JPH07173078A (en) * 1993-12-21 1995-07-11 Taisho Pharmaceut Co Ltd Antipruitic composition
JPH1036883A (en) * 1996-07-16 1998-02-10 Asahi Chem Ind Co Ltd Detergent composition for skin and hair
JPH10330217A (en) * 1997-05-29 1998-12-15 Kose Corp Skin whitening preparation for external use
JPH11106307A (en) * 1997-09-30 1999-04-20 Pola Chem Ind Inc Sulfite-containing soap
WO2004078157A2 (en) * 2003-03-04 2004-09-16 The Procter & Gamble Company Regulation of mammalian hair growth
JP2004256805A (en) * 2003-02-07 2004-09-16 Kao Corp Framed soap composition
WO2005018320A1 (en) * 2003-08-12 2005-03-03 The William M. Yarbrough Foundation Composition for treatment of biting and penetrating organisms and parasites, and urticaria and method of use

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07126158A (en) * 1993-10-27 1995-05-16 Taisho Pharmaceut Co Ltd Crotamiton-blended external preparation
JPH07173078A (en) * 1993-12-21 1995-07-11 Taisho Pharmaceut Co Ltd Antipruitic composition
JPH1036883A (en) * 1996-07-16 1998-02-10 Asahi Chem Ind Co Ltd Detergent composition for skin and hair
JPH10330217A (en) * 1997-05-29 1998-12-15 Kose Corp Skin whitening preparation for external use
JPH11106307A (en) * 1997-09-30 1999-04-20 Pola Chem Ind Inc Sulfite-containing soap
JP2004256805A (en) * 2003-02-07 2004-09-16 Kao Corp Framed soap composition
WO2004078157A2 (en) * 2003-03-04 2004-09-16 The Procter & Gamble Company Regulation of mammalian hair growth
WO2005018320A1 (en) * 2003-08-12 2005-03-03 The William M. Yarbrough Foundation Composition for treatment of biting and penetrating organisms and parasites, and urticaria and method of use

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2493955A (en) * 2011-08-25 2013-02-27 Hds Ltd Methods and compositions for reducing allergic reactions to fragranced products and perfumes
WO2021204568A1 (en) 2020-04-07 2021-10-14 Universität Basel A topical composition for treatment of pruritus

Also Published As

Publication number Publication date
JP5063072B2 (en) 2012-10-31
JP2008088100A (en) 2008-04-17

Similar Documents

Publication Publication Date Title
CA2567575C (en) Organo-gel formulations for therapeutic applications
JP5694665B2 (en) Topical preparation and its usage
US7740875B2 (en) Organo-gel formulations for therapeutic applications
JP4133837B2 (en) Skin moisturizing gel and method
JP2009184951A (en) External skin care preparation composition
JPH0215023A (en) Anesthetic/skin humidifying composition and production thereof
JP6921493B2 (en) Oil-in-water emulsified composition
JP2015530380A (en) Composition for treating psoriasis
JP2000143486A (en) Skin preparation for external use
JP6753312B2 (en) Topical skin preparation for medical use
WO2008038807A1 (en) External composition for skin
KR20140110168A (en) Cosmetic composition for improving acne
JP2000297044A (en) Transdermal patch for external use for skin
JP2012092067A (en) Nonsteroidal anti-inflammatory analgesic agent for external use
EP1014926B1 (en) Therapeutic and cosmetic compositions, their use and method for the preparation thereof
HU218946B (en) Topical use of anorganic salts of stroncium (ii) for producing pharmaceutical compositions for treating eye pruritis, eye- and eyelid-acs and eye-and eyelid dysaesthesia
US20040072789A1 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
JP5565995B2 (en) Antipruritic
JP7329910B2 (en) Skin topical composition
JP7312527B2 (en) emulsion composition
JPH08165244A (en) Dermatosis therapeutic agent
JP2022178149A (en) external composition
JP2000143518A (en) Preparation for external use for skin
JPWO2020116570A1 (en) External skin preparation
JP2018108957A (en) External composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07828852

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07828852

Country of ref document: EP

Kind code of ref document: A1